Page last updated: 2024-11-05

3,4,5,6-tetrahydrophthalic acid anhydride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,4,5,6-tetrahydrophthalic acid anhydride: RN given refers to cpd with locants as specified [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID12475
SCHEMBL ID40325
MeSH IDM0068755

Synonyms (43)

Synonym
AC-3369
3,4,5,6-tetrahydrophthalic anhydride
nsc61333
nsc-61333
1, 4,5,6,7-tetrahydro-
nsc-11211
2426-02-0
nsc11211
3,4,5,6-tetrahydrophthalic anhydride, 95%
1-cyclohexene-1,2-dicarboxylic anhydride
C1701
inchi=1/c8h8o3/c9-7-5-3-1-2-4-6(5)8(10)11-7/h1-4h2
hmmbjowwrlzemi-uhfffaoysa-
4,5,6,7-tetrahydro-2-benzofuran-1,3-dione
STK802233
AKOS005622564
A817177
cyclohexene-1,2-dicarboxylic anhydride
unii-01d3m89a2w
nsc 61333
3,4,5,6-tetrahydrophthalic acid anhydride
nsc 11211
01d3m89a2w ,
einecs 219-374-3
1,3-isobenzofurandione, 4,5,6,7-tetrahydro-
4,5,6,7-tetrahydroisobenzofuran-1,3-dione ,
FT-0607668
BBL027544
SCHEMBL40325
4,5,6,7-tetrahydro-isobenzofuran-1,3-dione
cyclohexene-1,2-dicarboxylic acid anhydride
4,5,6,7-tetrahydro-2-benzofuran-1,3-dione #
DTXSID9075298
mfcd00005917
J-514054
1,3,4,5,6,7-hexahydro-2-benzofuran-1,3-dione
3,4,5,6-tetrahydrophthalic anhydride, >=95%
J-015421
delta-tpa
AS-14503
Q27231422
D89450
EN300-119260
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (50.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.52 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.39 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.52)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]